Antimicrobial stewardship program may help reduce antimicrobial resistance in Intensive Care Unit. Clinical Microbiology and Infection 2008; 14 (S7): P1287.
62. Cavattoni IM, Morello E, Amato B, Casini M, Vedovelli C, Mian P, Pagani L. Prophylaxis of respiratory tract invasive fungal infections with aerosolized amphotericin-B deoxycholate in allogeneic hematopoietic stem cell transplant recipients. Clinical Microbiology and Infection 2008; 14(S7): P1546.
63. Moser B, Pagani L, Aschbacher R, Falciani M, Zanon P, Moser B. Antimicrobial stewardship program may reduce MRSA in Intensive Care Unit. Minerva Anestesiologica 2008; 74 (Suppl.2):
36. C113.
64. Pagani L, Falciani M, Aschbacher R, Spoladore G, Vedovelli C, Santa PJ, Larcher C, Mian P. Prevenire le resistenze batteriche e ottimizzare l’uso degli antibiotici in Terapia Intensiva: il ruolo della “Antimicrobial Stewardship”. Giornale Italiano di Farmacia Clinica 2008; 22: 143.
65. Moling O, Rimenti G, Presterà R, Vedovelli C, Pagani L, Spoladore G, Mian P. Acidosi lattica letale precipitata da nifedipina in un individuo trattato con terapia antiretrovirale, disulfiram e aminotriptilina. Atti del IV Workshop Nazionale sulle reazioni avverse da farmaci antiretrovirali; Milano 22-23 Gennaio 2009. Abstr. N. P28, p. 70-71.
66. Pagani L, Falciani M, Aschbacher R, Spoladore G, Larcher C, Mian P. Impact of an antimicrobial stewardship programme on antimicrobial consumption and cost in an Italian hospital. Clinical Microbiology and Infection 2009; 15 (Suppl. 4). Abstr. n. R2145.
67. Falciani M, Pagani L, Aschbacher R, Santa PJ, Vidoni S, Agreiter I, Lopez M, Larcher C,
Mian P. Efficacia di un Antimicrobial Management Program nella riduzione del consumo ospedaliero di antibiotici. Atti del 25° Congresso Nazionale della Società Italiana di Chemioterapia; Udine, 11-14 October 2009; abstr. No. P11, p.20.
68. Moling O, Passler W, Rimenti G, Pagani L, Vedovelli C, Mian P. Low vitamin D blood levels in 102 consecutive individuals taking antiretroviral therapy. HIV Medicine 2009; 10 (Suppl.2):
135.
69. Pagani L, Vernaz N, Aschbacher R, Falciani M, Mian P, Schwarz A. Antimicrobial stewardship improves appropriateness of antimicrobial therapy prescription in a neurosurgical unit. Clinical Microbiology and Infection 2010; 16 (Suppl. 2). Abstr. O.88.
70. Aschbacher R, Pagani L, Spoladore G, Innocenti P, Moroder L, Meyer R, Pagani E, Livermore DM, Larcher C. Metallo-beta-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary care hospital and long-term care facilities during 2009. Clinical Microbiology and Infection 2010; 16 (Suppl.2). Abstr. P.1280.
71. Vernaz N, Aschbacher R, Moser B, Harbarth S, Mian P, Bonnabry P, Pagani L. Efficacy and efficiency of a restrictive antibiotic policy on MRSA in the Intensive Care Unit. Clinical Microbiology and Infection 2010; 16 (Suppl. 2). Abstr. O.89.
72. Pagani L, Aschbacher R, Vernaz N, Falciani M, Mian P, Moser B, Zanon P. Implementing antimicrobial stewardship and control of antibiotic prescription to decrease MRSA in the Intensive Care Unit. Clinical Microbiology and Infection 2010; 16 (Suppl. 2). Abstr. P.1413.
73. Agreiter I, Pagani L, Mian P. Reviewing internet resources about prevention and risk management of hospital infections in Italy. Journal of Hospital Infection 2010; 76 (Suppl. 1): S59-S60.
74. Pagani L, Aschbacher R, Schwarz A, Mian P. Impact of antimicrobial stewardship on antibiotic usage and expenditures in a neurosurgical unit (NSU). Proc ICAAC 2010; Abstr. No. O-2210.
75. Agreiter I, Pagani L, Palermo N, Spinell A, Purin D, Paulmichl RR. Le infezioni urinarie associate a catetere vescicale: applicabilità delle linee guida IDSA attraverso il processo infermieristico. Atti del Congresso Nazionale ANIPIO 2010.
76. Pagani L. Resistenze batteriche, appropriatezza terapeutica e uso razionale delle risorse: la sfida dell'Antimicrobial Stewardship. Giornale Italiano delle Infezioni Ospedaliere 2011.
77. Agreiter I, Pagani L. Navigando il web alla ricerca di risorse sul risk management nelle infezioni ospedaliere. Giornale Italiano delle Infezioni Ospedaliere 2011; 1: 11-12.
78. Pagani L, Aschbacher R, Cecchi P, Vidoni S, Spoladore G, Mian P, Schwarz A. Role of the infectious diseases consultant in improving antimicrobial therapy prescription in neurosurgery.
BMC Proceedings 2011; 5 (Suppl. 6): P154.
79. Pagani L. Perils of inappropriate antibiotic exposure in cancer patients. A call to fast-acting synergy. BMC Proceedings 2011; 5 (Suppl. 6): P52.
80. Agreiter I, Pagani L, Motter E, Pedrotti E, Mian P. Needlestick injuries: a prickly need for improving prevention. BMC Proceedings 2011; 5 (Suppl. 6): P222.
81. Pagani L, Coser S, Aschbacher R. Appropriate management of endogenous endophthalmitis: no longer a question for singles. XX Congress of International Society for Eye Research (ISER);
Berlin. 2012; p. 206. P069.
82. Iten A, Schindler M, Zingg W, Pagani L, Uçkay I, Pittet D. Epidemiology of adverse events associated with prolonged antibiotic therapy for osteoarticular infections. ICAAC 2012; Abstr. K-2075.
83. Landelle C, Schindler M, Zingg W, Pagani L, Uçkay I, Pittet D. Does the antibiotic combination with rifampin for osteoarticular infections protect against colitis due to Clostridium difficile? ICAAC 2012; Abstr. K-929.
84. Pagani L, Sauvan V, Iten A, Kaiser L, Harbarth S, Pittet D. Nosocomial outbreak of seasonal influenza in a geriatric hospital. ICAAC 2012; Abstr. K-954.
85. Iten A, Schibler M, Pagani L, Thomas Y, Camus V, Kaiser L, Perrier A, Pittet D. Epidemic of seasonal influenza in an internal medicine service. ICAAC 2012; Abstr. K-956.
86. Pagani L, Beović B. Linking antibiotic consumption and resistance surveillance: international and regional perspective. 3rd SEEC; 2012; Dubrovnik.
87. Bouvet C, Lübbeke A, Pagani L, Bandi C, Uçkay I, Hoffmeyer P. No need for search of asymptomatic urinary tract colonization before elective hip and knee arthroplasty. Swiss Medical Weekly 2013; 143 (Suppl. 198): S49-S50.
88. Pagani L, Sauvan V, Thomas Y, Iten A, Huttner B, Kaiser L, Pittet D, Harbarth S. In-hospital epidemics of seasonal influenza A/H3N2 in a geriatric facility. Antimicrobial Resistance and Infection Control 2013; 2 (S1): P36.
89. Huttner B, Cordey S, Sauvan V, Pagani L, Iten A, Kaiser L, Reny J-L, Harbarth S. An outbreak of norovirus strain GII.4 Sydney in a geriatric teaching hospital. Antimicrobial Resistance and Infection Control 2013; 2 (S1): O73.
90. Agostinho A, Sauvan V, Pagani L, Hoffmeyer P, Harbarth S, Uçkay I. Validation of a simple tool to save resources with previous MRSA carriers. Antimicrobial Resistance and Infection Control 2013; 2 (S1): P46.
91. Sauvan V, Registe Rameau Y, Pagani L, Pittet D, Harbarth S. Surveillance in geriatrics: what for? Which indicators? Antimicrobial Resistance and Infection Control 2013; 2 (S1): P238.
92. Sauvan V, Registe Rameau Y, Pagani L, Pittet D. Is patient participation useful to improve staff hand hygiene compliance in a geriatric hospital? Antimicrobial Resistance and Infection Control 2013; 2 (S1): P169.
93. Uçkay I, Pagani L, Bouvet C, Agostinho A, Hoffmeyer P, Pittet D. Futility of perioperative urinary analysis before elective total joint arthroplasty. Antimicrobial Resistance and Infection Control 2013; 2 (S1): P197.
94. Pagani L. The role of ID specialist in improving antimicrobial therapy in ICU. 5th Eurasia Congress of Infectious Diseases, EACID 2013; Tirana, May 15-18, 2013. p. 71.
95. Huttner A, Von Dach E, Renzoni A, Affaticati M, Huttner B, Pagani L, Daali Y, Pugin J, Karmime A, Fathi M, Harbarth S. Augmented renal clearance, subtherapeutic beta-lactam concentrations and clinical outcomes in the critically ill. ICAAC Abstract Book 2013; Abstr. A-475.
96. Harbarth S, von Dach E, Pagani L, Macedo-Viñas M, Olearo F, Huttner B, Emonet S, Uçkay I. Randomized clinical trial to compare trimethoprim-sulfamethoxazole (TMP-SMX) plus rifampicin versus linezolid alone in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. ICAAC Abstract Book 2014; Abstr. K-1901.
97. Bru JP, Pagani L, Vitrat V, Jehl F, Bland S, Beaune G, Tolsma V. PK/PD de l’amoxicilline administrée par voie orale (Avo) chez des patients ayant des infections difficiles dues à des bactéries à gram + nécessitant des traitements de longue durée. Médecine et Maladies Infectieuses 2014; 44 (HS1): p. 70. M-16.
98. Forestier E, Roubaud-Baudron C, Fraisse T, Paccalin M, Pagani L, Gaillat J. subcutaneously administered antibiotics: a national survey of current practice from the French infectious diseases (SPILF) and geriatric medicine (SFGG) societies’ network. ECCMID Abstract Book 2014; Abstr.
P0278.
99. Pagani L, Vitrat V, Janssen C, Jehl F, Renzoni A, Gaillat J, Bru J-P.
Pharmacokinetic/pharmacodynamic (PK/PD) profile of oral amoxicillin in elderly patients with gram-positive infections requiring prolonged antimicrobial courses. ECCMID Abstract Book 2014; Abstr. P1926.
100. Vitrat V, Jean A, Fiot J, Janssen C, Nguyen S, Guerin F, Pagani L. An audit and feedback strategy does not improve compliance with surgical antimicrobial prophylaxis guidelines.
Antimicrobial Resistance and Infection Control 2015; 4 (S1): P82.
101. Fonteille A, Janssen C, Tolsma V, M’Biene S, Dalla-Zuanna S, Moulin P, Antoine M, Bru J-P, Pagani L. Coronary artery calcium score (CACS) for the screening of silent coronary disease in HIV-patients on HAART. ECCMID 2015 Abstract Book; Abstr. P0558.
102. Tolsma V, Vitrat V, Bru J-P, Beaune G, Petitprez H, Piet E, Pagani L. Stability and efficacy of cloxacillin (CLX) in continuous infusion (CI) over 24 hours. ICAAC/ICC 2015 Abstract Book;
Abstr. A-2579.
103. Vitrat V, Janssen C, Bland S, Guerin F, Jean A, Pagani L. Evaluation of an Antimicrobial Stewardship Program (ASP) in a French tertiary care hospital. ICAAC/ICC 2015 Abstract Book;
Abstr. S-433.
104. Roubaud Baudron C, Forestier E, Fraisse T, Gaillat J, Bernard L, Pagani L, Gavazzi G, Paccalin M. Tolerance of subcutaneously administered antibiotics: a national, prospective and observational study. European Geriatric Medicine 2015; 6 (S1): S18. Abstr. O-046.
105. Beovic B, Dousak M, Pulcini C, Beraud G, Vlahovic-Palcevski V, Kofteridis D, Kostyanev T, Carevic B, Cortez J, Wechsler-Fördös A, Pagani L, Klesnik M, Nadrah K, Uhan S, Nathwani D, on behalf of ESGAP and TAE. Young doctors’ perspective on antibiotic use and resistance in Europe in 2015 (YPAR): preliminary results. ECCMID 2016 Abstract Book; Abstr.
P1302.
106. Roubaud-Baudron C, Forestier E, Fraisse T, Gaillat J, de Wazières B, Pagani L, Ingrand I, Bernard L, Gavazzi G, Paccalin M. Tolerance of ceftriaxone administrated subcutaneously. A French prospective multicentre observational study. ECCMID 2016 Abstract Book; Abstr.
EV0704.
107. Beovic B, Dousak M, Pulcini C, Beraud G, Pano-Pardo J, Kofteridis D, Cortez Alvarez J, Pagani L, Klesnik M, Nadrah K, Uhan S, Hafner Fink M, Nathwani D. Young doctors’
perspectives on antimicrobial use and resistance in Europe: preliminary results of the YPAR study. ECCMID 2017 Abstract Book; Abstr. P1116.
108. Harbarth S, von Dach E, Morel C, Murthy A, Pagani L, Macedo Vinas M, Olearo F.
Comparing the cost-effectiveness of linezolid (LZD) to trimethoprim/sulfamethoxazole (TMP-SMX) plus rifampicin (RMP) for the treatment of MRSA infection: a health-care system perspective. ECCMID 2017 Abstract Book; Abstr. EV0441.
109. Pagani L. Antibiotics and antibiotic resistance as a major problem for health and environment: an overview. Euregio Conference: Water as a natural resource in a changing environment. 2017, Bolzano.
110. Weiss E, Ewig S, Zahar JR, Adler J, Asehnoune K, Bassetti M, Bonten M, Chastre J, De Waele J, Dimopoulos G, Eggimann Ph, Engelhardt M, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer L, Papazian L, Poulakou G, Prokocimer Ph, Rello J, Rex J.
Elaboration of a consensus endpoint to evaluate antimicrobial treatment efficacy in future HAP VAP clinical trials. Annals of Intensive Care 2018; 8 (Suppl 1): F-36.
111. Yahav D, Babich T, Paul M, Pulcini C, Cano Yuste A, Beovic B, Pagani L, Kofteridis D, Rodriguez-Bano J, Oliver A, Nesher L, Chazan B, Landes M, McCarthy K, Gonzalez-Barbera EM, Gozalo Margüello M, Maurer S, Grier S, Cardona Corrales R, Karlsson-Valik J, Leibovici L. Carbapenems, ceftazidime or piperacillin/tazobactam monotherapy for Pseudomonas aeruginosa bacteraemia—an international multicentre retrospective study. ECCMID 2018 Abstract Book; Abstr. P0662.
112. Murri R, Giovannenze F, Kallen M, Pagani L, Tebano G, Pulcini C, Schouten J, Fantoni M.
Indagine sulle risorse di antimicrobial stewardship presenti in 65 centri clinici italiani. Infezioni in Medicina 2018; 26 (S1): 157. PO 007.
113. Babich T, Naucler P, Valik JK, Benito N, Cardona Corrales R, Pulcini C, Fattah MA, Macgowan A, Grier S, Gibbs J, Ben-Ami R, Nesher L, McCarthy K, Paterson DL,
Tacconelli E, Rodriguez-Bano J, Morales I, Oliver A Ruiz E, Cano Yuste A, Machuca Sanchez I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Salavert M, Beovic B, Saje A, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Paul M, Leibovici L, Yahav D. Risk factors for 30-day mortality among hospitalised patients with Pseudomonas aeruginosa bacteraemia: a multicentre retrospective study. ECCMID 2019 Abstract Book; Abstr.
P2414.
114. Pagani L, Vedovelli C, Binazzi R, Spoladore G, Pagani E, Aschbacher R. Tackling Antimicrobial Resistance (AMR) effectively: ten years of successful antimicrobial stewardship program in a tertiary care hospital in Italy. World One Health Congress 2020; Edinburgh; Abstr.
699.
115. Babich T, Naucler P, Karlsson J, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Abdel Fattah M, Haquin J, MacGowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, Ruiz de Gopegui E, Cano A, Machuca I, Gozalo-Marguello M, Martinez LM, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Antibiotic combination versus monotherapy for the treatment of Pseudomonas aeruginosa bacteraemia: a multicentre retrospective study. ECCMID 2020 Abstract Book; Abstr.
4517.
116. Aschbacher R, Vedovelli C, Spoladore G, Binazzi R, Falciani M, Santa PJ, Pagani E, Pagani L. Ten years of antimicrobial stewardship in a tertiary care hospital in northern Italy. ECCMID 2020 Abstract Book; Abstr. 2623.